Skip to main content
Give
Division of Nephrology
DepartmentsDepartment of MedicineDivisionsDivision of NephrologyPublications2014 Divisional Bibliography

2014 Divisional Bibliography

Peer Reviewed

  1. Agarwal R, Flynn J, Pogue V, Rahman M, Reisin E, Weir MR. Assessment and Management of Hypertension in Patients on Dialysis. J Am Soc Nephrol. 2014 Aug;25(8):1630-46.
  2. Arking DE, Pulit SL,Parsa A et al. (middle author) Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014 Aug;46(8):826-36.
  3. Armando I, Konkalmatt P, Felder RA, Jose PA. The renal dopaminergic system: novel diagnostic and therapeutic approaches in hypertension and kidney disease. Transl Res. 2014 Jul 25. pii: S1931-5244(14)00269-2 (Review).
  4. Armando I, Villar VA, Jones JE, Lee H, Wang X, Asico LD, Yu P, Yang J, Escano CS Jr, Pascua-Crusan AM, Felder RA, Jose PA. Dopamine D3 receptor inhibits the ubiquitin-specific peptidase 48 to promote NHE3 degradation. FASEB J. 2014 Mar;28(3):1422-34.
  5. Arnaldo FB, Villar VA, Konkalmatt PR, Owens SA, Asico LD, Jones JE, Yang J, Lovett DL, Armando I, Jose PA, Concepcion GP. D1-like dopamine receptors downregulate Na+-K+-ATPase activity and increase cAMP production in the posterior gills of the blue crab Callinectes sapidus. Am J Physiol Regul Integr Comp Physiol. 2014 Sep 15;307(6):R634-42.
  6. Cai J, Wu G, Tan X, Han Y, Chen C, Li C, Wang N, Zou X, Chen X, Zhou F, He D, Zhou L, Jose PA, Zeng C. Transferred BCR/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice. PLoS One. 2014 Aug 18;9(8):e105200.
  7. Carpenter MA, John A, Weir MR, Smith SR, Hunsicker L, Kasiske BL, Kusek JW, Bostom A, Ivanova A, Levey AS, Solomon S, Pesavento T, Weiner DE. BP, cardiovascular disease , and death in the folic acid for vascular outcome reduction in transplantation trial. J Am Soc Nephrol. 2014 Jul;25(7):1554-62.
  8. Cebotaru V, Cebotaru L, Kim H, Chiaravalli M, Boletta A, Qian F, Guggino WB. Polycystin-1 negatively regulates polycystin-2 expression via the aggresome/autophagosome pathway. J Biol Chem, 2014 Mar 7;289(10):6404-14.
  9. Cebotaru L, Rapino D, Cebotaru V, Guggino WB. Correcting the Cystic Fibrosis Disease Mutant, A455E CFTR. PLoS One. 2014 Jan 8;9(1):e85183.
  10. Chen K, Fu C, Chen C, Liu L, Ren H, Han Y, Yang J, He D, Zhou L, Yang Z, Zhang L, Jose PA, Zeng C. Role of GRK4 in the regulation of arterial AT1 receptor in hypertension. Hypertension. 2014 Feb;63(2):289-96.
  11. Davis-Ajami ML, Wu J, Fink JC Differences in health services utilization and costs between antihypertensive medication users versus nonusers in adults with diabetes and concomitant hypertension from Medical Expenditure Panel Survey pooled years 2006 to 2009. Value Health. 2014 Jan-Feb;17(1):51-61
  12. DeSilva L, Diamantidis CJ, Prakash D, Zuckerman M, Weir MR. Usability of Mobile Technology to Screen for Drug-Drug Interactions in Kidney Transplant Patients. Am J Nephrol. 2014 Jul 19;40(2):97-104.
  13. Ennis RC, Asico LD, Armando I, Yang J, Feranil JB, Jurgens JA, Escano CS Jr, Yu P, Wang X, Sibley DR, Jose PA, Villar VA. Dopamine D1-like receptors regulate the ?1A-adrenergic receptor in human renal proximal tubule cells and D1-like dopamine receptor knockout mice. Am J Physiol Renal Physiol. 2014 Dec 1;307(11):F1238-48.
  14. Fonseca J, Bastos A, Amaral A, Sousa M, Souza L, Malheiros D, Piontek K, Irigoyen M, Watnick T, Onuchic L. Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice. Kidney Int 85: 1137-50, 2014.
  15. Fu J, Han Y, Wang H, Wang Z, Liu Y, Chen X, Cai Y, Guan W, Yang D, Asico LD, Zhou L, Jose PA, Zeng C. Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats. Cardiovasc Diabetol. 2014 Feb 22;13:50.
  16. Gildea JJ, Shah IT, Van Sciver RE, Israel JA, Enzensperger C, McGrath HE, Jose PA, Felder RA. The cooperative roles of the dopamine receptors, D1R and D5R, on the regulation of renal sodium transport. Kidney Int. 2014 Jul;86(1):118-26.
  17. Ginsberg JS, Zhan M, Diamantidis CJ, Woods C, Chen J, Fink JC. Patient-reported and actionable safety events in chronic kidney disease. J Am Soc Nephrol, 2014, 25:1564-73
  18. Grunwald JE, Pistilli M, Ying GS, Daniel E, Maguire MG, Xie D, Whittock-Martin R, Parker Ostroff C, Lo JC, Townsend RR, Gadegbeku CA, Lash JP, Fink JC, Rahman M, Feldman HI, Kusek JW; the Chronic Renal Insufficiency Cohort Study Investigators. Clin J Am Soc Nephrol 2014, 9(7):1217-24.
  19. Jiang X, Konkalmatt P, Yang Y, Gildea J, Jones JE, Cuevas S, Felder RA, Jose PA, Armando I. Single-nucleotide polymorphisms of the dopamine D2 receptor increase inflammation and fibrosis in human renal proximal tubule cells. Hypertension. 2014 Mar;63(3):e74-80.
  20. Kim, H., Xu1, H., Yao1, Q., Li, W., Huang, Q., Outeda, P., Cebotaru, V., Chiaravalli, M., Boletta, A., Piontek, K., Weinman, E.J., Germino, G.G., Watnick, T., and Qian, F.: Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanism. Nat. Commun. 5:5482, 2014.
  21. Lakkis JI, Weir MR. Treatment-Resistant Hypertension in the Transplant Recipient. Semin Nephrol. 2014;34(5):560-570.
  22. Lee H, Abe Y, Lee I, Shrivastav S, Crusan AP, Hüttemann M, Hopfer U, Felder RA, Asico LD, Armando I, Jose PA, Kopp JB. Increased mitochondrial activity in renal proximal tubule cells from young spontaneously hypertensive rats. Kidney Int. (2014) 85, 561–569.
  23. Liu D, Wang CJ, Judge DP, Halushka MK, Ni J, Habashi JP, Moslehi J, Bedja D, Gabrielson KL, Xu H, Qian F, Huso D, Dietz HC, Germino GG, Watnick T. A Pkd1-Fbn1 genetic interaction implicates TGF-b-Signaling in the pathogenesis of vascular complications in ADPKD. J Am Soc Nephrol 25: 81-91, 2014.
  24. Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS. Performance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis. Hepatology. 2014 Apr; 59(4):1532-42.
  25. Mindikoglu AL, Dowling TC, Wong-You-Cheong JJ, Christenson RH, Magder LS, Hutson WR, Seliger SL, Weir MR. A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements. Am J Nephrol. 2014;39(6):543-52.
  26. Outeda P, Huso DL, Fisher SA, Halushka MK, Kim H, Qian F, Germino GG and Watnick T. Polycystin signaling is required for directed endothelial cell migration and lymphatic development. Cell Reports 7: 634-44, 2014.
  27. Pallone TL. Complex vascular bundles, thick ascending limbs and aquaporins: wringing out the outer medulla. Am J Physiol Renal Physiol. 2014 Mar;306(5):F505-6.
  28. Parsa A., Freedman B. Generalizability of genetic findings related to kidney function and albuminuria. Clin J Am Soc Nephrol. 2014 Jan;9(1):8-11. (Invited Editorial)
  29. Patel AM, Rame JG, Rudnick MR. How Does the Nephrologist Manage an LVAD Patient on Chronic Maintenance Dialysis? Seminars in Dialysis 2014; 27(3): 284-288
  30. Ricardo AC, Yang W, Lora CM, Gordon EJ, Diamantidis CJ, Ford V, Kusek JW, Lopez A, Lustigova E, Nessel L, Rosas SE, Steigerwalt S, Theurer J, Zhang X, Fischer MJ, Lash JP. “Limited health literacy is associated with low glomerular filtration in the Chronic Renal Insufficiency Cohort (CRIC) study.” Clinical Nephrology. 2014 Jan;81(1):30-7.
  31. Salimi S, Nawi N, Seliger S, Parsa A. Periodontal Disease, Renal Dysfunction and Heightened Leukocytosis. Nephron Clin Pract. 2014 Nov 8.
  32. Sanada H, Yokokawa H, Yatabe J, Williams SM, Felder RA, Jose PA, Takenosita S. Association between lifestyle-related disorders and visceral fat mass in Japanese males: a hospital based cross-sectional study. Environ Health Prev Med. 2014 Nov;19(6):429-35.
  33. Tan M, Wettersten HI, Chu K, Huso DL, Watnick T, Friedlander S, Landesman Y, Weiss RH. Novel inhibitors of nuclear transport cause cell cycle arrest and decrease cyst growth in ADPKD associated with decreased cdk4 levels. Am J Physiol Renal Physiol. In Press, 2014
  34. Tragante V, Barnes MR, Ganesh SK,…Parsa A et al. (middle author). Gene-centric meta-analysis in 87,736 individuals of European ancestry identifies multiple blood-pressure-related loci. .Am J Hum Genet. 2014 Mar 6;94(3):349-60.
  35. Wang S, Lu X, Yang J, Wang H, Chen C, Han Y, Ren H, Zheng S, He D, Zhou L, Asico LD, Wang WE, Jose PA, Zeng C. Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells. Am J Physiol Renal Physiol. 2014 Mar 15;306(6):F588-96.
  36. Wang X, Luo H, Chen C, Chen K, Wang J, Cai Y, Zheng S, Yang X, Zhou L, Jose PA, Zeng C. Prenatal lipopolysaccharide exposure results in dysfunction of the renal dopamine D1 receptor in offspring. Free Radic Biol Med. 2014 Nov;76:242-50.
  37. Weir MR, Townsend RR. Refractory Hypertension: An Important Clinical Phenotype. Hypertension. 2014. Mar; 63(3):447-8.
  38. Weir MR, Townsend RR. Vascular Stiffness as a Surrogate Measure of Mortality in Patients with Chronic Kidney Disease. J Hypertens. 2014 Apr; 32 (4):744-5.
  39. Weir MR, Fink JC. Safety of Medical Therapy in Patients with Chronic Kidney Disease and End-Stage Renal Disease. Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13.
  40. Weir MR, Kline I, Xie J, Edwards R, Usiskin K. Effect of canagliflozin on serum electrolytes in patients with type 2 diabetes in relation to estimated glomerular filtration rate (eGFR). Curr Med Res Opin. 2014 Sep;30(9):1759-68.
  41. Weir MR. Hypertension and kidney disease. J Am Soc Hypertens. 2014 Nov;8(11):855-7.
  42. Weir MR. In the Clinic: Hypertension. Ann Intern Med. 2014 Dec 2;161(11).
  43. Yang, Y., Cuevas, S., Yang, S., Villar, V.A., Escano, C., Asico, L., Yu,P., Jiang, X., Weinman, E.J., Armando, I., and Jose, P.: Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of ROS production. Hypertension. 64:825-832, 2014.
  44. Yang J, Armando I, Jones JE, Zeng C, Jose PA, Villar VM. Sorting nexins: New determinants for the development of hypertension. Ann Clin Exp Hypertens 2014;2:1008 (review).
  45. Yang Y, Cuevas S, Yang S, Villar VA, Escano C, Asico L, Yu P, Jiang X, Weinman EJ, Armando I, Jose PA. Sestrin2 decreases renal oxidative stress, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of reactive oxygen species production. Hypertension. 2014 Oct;64(4):825-32.
  46. Yokokawa H, Goto A, Sanada H, Watanabe T, Felder RA, Jose PA, Yasumura S. Association between control to target blood pressures and healthy lifestyle factors among Japanese hypertensive patients: longitudinal data analysis from Fukushima Research of Hypertension (FRESH). Obes Res Clin Pract. 2014 Jul-Aug;8(4):e364-73.
  47. Yu, P., Sun, M., Villar, V.A., Zhang, Y., Weinman, E.J., Felder, R.A., and Jose, P.A.: Differential dopamine receptor subtype regulation of adenylyl cyclases in lipid rafts in human embryonic kidney and renal proximal tubule cells. Cell Signal. 26:2521-2529, 2014.
  48. Yu P, Han W, Villar VA, Yang Y, Lu Q, Lee H, Li F, Quinn MT, Gildea JJ, Felder RA, Jose PA. Unique role of NADPH oxidase 5 in oxidative stress in human renal proximal tubule cells. Redox Biol. 2014 Feb 22;2:570-9.
  49. Yu C, Wang Z, Han Y, Liu Y, Wang WE, Chen C, Wang H, Jose PA, Zeng C. Dopamine D? receptors inhibit proliferation and migration of vascular smooth muscle cells induced by insulin via down-regulation of insulin receptor expression. Cardiovasc Diabetol. 2014 Jun 2;13:97.
  50. Zhang Z, Lin H, Cao C, Payne K, Pallone TL. Descending vasa recta endothelial cells and pericytes form mural syncytia. Am J Physiol Renal Physiol. 2014 Apr;306(7):F751-63.
  51. Zhang Z, Payne K, Pallone TL. Syncytial communication in descending vasa recta includes myoendothelial coupling. Am J Physiol Renal Physiol. 307:F41-52, 2014.

Non-Peer Reviewed

  1. Weir MR, Fink JC. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease. Curr Opin Nephrol Hypertens. 2014 May;23(3):306-13.

Book Chapters

  1. Karadsheh F. Weir MR. Hematologic Complications of Chronic Kidney Disease: Leukocyte and Monocyte Function. In: P. Kimmel & M. Rosenberg, eds. Chronic Renal Disease. Oxford: Elsevier; 2014: 277-284.
  2. Thompson MD, Cole DE, Jose PA, Chidiac P. G protein-coupled receptor accessory proteins and signaling: pharmacogenomic insights. Methods Mol Biol. 2014;1175:121-52.
  3. Armando I, Jose PA. Hypertension. In Clinical Genomics: Practical Applications in Adult Patient Care, Murray MF, Babyatsky MW, Giovanni M MA. McGraw-Hill Education, 2014, pp 74-80.
  4. Jose PA, Villar VM, Weir MR, Felder RA. Pharmacogenomics of GPCR Signaling and other pathways in essential hypertension. In G Protein-Coupled Receptor Genetics: Research and Methods in the Post-Genomic Era, Methods in Pharmacology and Toxicology, Stevens CW(ed.), Springer Science+Business Media New York, 2014.
  5. Weir M and Mavanur M. The Use of Angiotensin-Converting Enzyme Inhibitors in the Renal Transplant Recipient. In: Macaulay Amechi Chuka Onuigbo, eds. Ace Inhibitors Medical Uses, Mechanisms of Action, Potential Adverse Effect and Related Topics; Nova Science Publishers, Inc. 2014: 191-202.